| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Aslan Fred is a President And CEO at Artiva Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $13.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | ARTV Artiva Biotherapeutics, Inc. | President And CEO | Sell | 3,187 | $6.00 | $19,122.00 | -0.3% | -1.9% | - | |
| Nov 17, 2025 | ARTV Artiva Biotherapeutics, Inc. | President And CEO | Sell | 6,375 | $3.38 | $21,522.00 | -1.8% | +17.1% | - | |
| Oct 17, 2025 | ARTV Artiva Biotherapeutics, Inc. | President And CEO | Sell | 25,500 | $6.00 | $153,000.00 | -6.7% | -25.8% | - | |
| Aug 15, 2025 | ARTV Artiva Biotherapeutics, Inc. | President And CEO | Sell | 25,500 | $2.73 | $69,579.30 | -6.2% | +23.3% | - |